Cardiac Insight
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2375 130th Ave NE Ste 101, Bellevue, Was...Phone Number
(206) 596-2060Website
www.cardiacinsightinc.comRevenue
$7.5 MillionIndustry
About Cardiac Insight
Cardiac Insight Org Chart
Is Cardiac Insight your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Cardiac Insight has recently received funding, and reach out quickly before it becomes old news!
Click to see if Cardiac Insight had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Cardiac Insight
Product Launch: Get notified when Cardiac Insight launches new products
Funding: Get notified immidiatlly once Cardiac Insight has new funding data
Cardiac Insight, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Cardiac Insight is spiking on competitors!
Earning: See what the market has to say on Cardiac Insight recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Cardiac Insight
Compare insights from companies similar to Cardiac Insight, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cardiac Insight is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cardiac Insight is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cardiac Insight.
Cardiac Insight financials insights
Gather financial insights about Cardiac Insight, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Multiple Rounds
$1.7M
Debt
$284K
Series B
$7M
Private Equity
$1M
Multiple Rounds
$11.8M
Series D
$8M
Debt
$350K
Cardiac Insight Tech Stack
A closer look at the technologies used by Cardiac Insight
Most Recent Scoops
Cardiac Insight News & Media
Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023
BELLEVUE, Wash.--(BUSINESS WIRE)-- #ECGscreening--Cardiac Insight, Inc., creators of Cardea SOLO™ prescription cardiac sensors and automated electrocardiography (ECG) Analysis Software, shares its perspective on the latest CMS ruling, which provides nationwide physician confidence in receiving the appropriate reimbursement for prescribing LT-ECG (Long Term ECG) ambulatory diagnostic testing. The new Medicare Physician Fee Schedule (MPFS) rule establishes national Medicare and Medicaid payment raCardiac Insight’s Cardea SOLO™ ECG System Named as Finalist in Fierce Innovation Awards Healthcare Edition
BELLEVUE, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, has been named a finalist in the 2022 Fierce Healthcare Innovation Awards for its Cardea SOLO™ ECG System. The awards recognize innovations that are transforming the healthcare industry. Cardiac Insight’s Cardea SOLO ECG system was selected by a panel of expertCardiac Insight Comments on CMS Plans to Establish Nationwide Payment for Long-Term ECG Monitoring in 2023
BELLEVUE, Wash.--(BUSINESS WIRE)-- #AFib--Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, shares its perspective on recent announcements impacting its served markets. These markets include the exponentially growing Atrial Fibrillation (AF) and the emerging ‘long COVID-19’ cardiac arrhythmia diagnostic market, both of which potentially impactCardiac Insight’s Cardea 20/20 ECG™ System Utilized by the United States Coast Guard Auxiliary in Conjunction With the USCG Academy Medical Clinic to Screen Newly Recruited USCG Academy Cadets for Risk of Sudden Cardiac Death (SCD)
BELLEVUE, Wash.--(BUSINESS WIRE)-- #ECGscreening--Sudden Cardiac Arrest (SCA) is the leading medical cause of death in young athletes during sport. The presence of congenital abnormalities and electrical abnormalities within the heart that cause SCA can be detected by performing a simple, noninvasive 12-lead ‘ECG’ test or electrocardiogram. The United States Coast Guard Auxiliary (USCGAUX) Health Services and USCG Academy has recognized the importance of screening for possible SCA and has suppor
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cardiac Insight
Cardiac Insight, Inc. a privately held medical device company based in Bellevue, WA., is renowned for its cardiac diagnostic products, Cardea SOLO and Cardea 20/20.... Read More